|
 |
| |
|
Ƽ½ëÆ®¸¯ÁÖ(¾ÆÅ×Á¹¸®ÁÖ¸¿) 20mL Tecentriq Inj.
|
|
Àü¹®ÀǾàǰ | ±Þ¿© | ½Å¾à
|
|
¼öÀÔÀǾàǰ
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ¹«»ö ³»Áö ¿¬ÇÑ ³ë¶û ¾×ü°¡ ÃæÀüµÈ ¹ÙÀÌ¾Ë ÁÖ»çÁ¦ |
|
|
|
|
|
Á¦Á¶È¸»ç |
(ÁÖ)Çѱ¹·Î½´
|
ÆÇ¸Åȸ»ç |
(ÁÖ)Çѱ¹·Î½´
|
Çã°¡Á¤º¸ |
Á¤»ó
(2017.01.12)
|
BIT ¾àÈ¿ºÐ·ù |
¸é¿ªÁ¶Àý Ç×¾ÏÁ¦(Immunomodulators)
|
º¹ÁöºÎºÐ·ù |
421[Ç׾ǼºÁ¾¾çÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
645001441 \2,261,034 ¿ø/20mL/º´(2024.07.01)(ÇöÀç¾à°¡)\2,271,109 ¿ø/20mL/º´(2022.05.01) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
atezolizumab / L01FF05 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¹é´ç,
¹é´ç,
¾Æ¼¼Æ®»ê¹«¼ö¹°,
¾Æ¼¼Æ®»ê¹«¼ö¹°,
ÁÖ»ç¿ë¼ö,
Æú¸®¼Ò¸£º£ÀÌÆ® 20,
Æú¸®¼Ò¸£º£ÀÌÆ®20,
L-È÷½ºÆ¼µò
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-02-16 |
|
|
|
|
| |
|
|
|